z-logo
Premium
Steroids and hypertension. 1‐Gas‐liquid chromatography and gas chromatography mass spectrometry of 3,15‐ and 3,16‐dihydroxy‐17‐oxosteroids
Author(s) -
Bègue R.J.,
Dumas M.,
Morinière M.,
Nivois C.,
Paidieu P.
Publication year - 1979
Publication title -
biomedical mass spectrometry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 121
eISSN - 1096-9888
pISSN - 0306-042X
DOI - 10.1002/bms.1200061104
Subject(s) - chemistry , chromatography , ether , trimethylsilyl , alpha (finance) , beta (programming language) , elution , gas chromatography , mass spectrum , steroid , mass spectrometry , organic chemistry , biochemistry , hormone , medicine , construct validity , nursing , computer science , patient satisfaction , programming language
In order to analyse and quantitate the urinary 16‐oxysteroids known or thought to be associated with hypertension, we have established for six 16‐oxy‐C19 reference steroids the following parameters: elution volume on lipophilic gel columns, gas chromatographic retention data expressed as methylene unit values of trimethylsilyl ether and O ‐methoxime trimethylsilyl ether derivatives on OV‐1 and OV‐17 packed columuns and on SE‐30 capillary column, and mass spectra of these compounds. These reference steroids were: 3α, 16α‐dihydroxy‐5α‐androstan‐17 one, 3α,16α‐dihydroxy‐5β‐androstan‐17‐one, 3β,16α‐dihydroxy‐5α‐androstan‐17‐one, 3β,16α‐dihydroxy‐5‐androsten‐17‐one, 3β,16β‐dihydroxy‐5‐androsten‐17‐one, 3β,17β‐dihydroxy‐5‐androsten‐16‐one and 3α,15α‐dihydroxy‐5β‐androstan‐17‐one. The proposed method was shown to be applicable to the specific analysis of 16‐oxy‐C19‐steroids in biological samples since it achieved the selective isolation of these compounds from other steroids and their quantitative elution in a single fraction. The analysis of the urinary steroids of two patients with arterial hypertension demonstrated an elevated rate of 3β,16α‐dihydroxy‐5‐androstan‐17‐one.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here